Qiagen N.V. (ETR: QIA)
Germany
· Delayed Price · Currency is EUR
45.17
+0.23 (0.51%)
Jan 20, 2025, 5:35 PM CET
Qiagen Revenue
Qiagen had revenue of $501.87M USD in the quarter ending September 30, 2024, with 5.46% growth. This brings the company's revenue in the last twelve months to $1.97B, up 0.62% year-over-year. In the year 2023, Qiagen had annual revenue of $1.97B, down -8.23%.
Revenue (ttm)
$1.97B
Revenue Growth
+0.62%
P/S Ratio
n/a
Revenue / Employee
$355.48K
Employees
5,531
Market Cap
9.93B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 20.96B |
Siemens Healthineers AG | 22.36B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.32B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.07B |
SCHOTT Pharma AG & Co. KGaA | 957.09M |
Qiagen News
- 4 days ago - QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - Business Wire
- 5 days ago - Qiagen NV (QGEN) Announces Fourth Quarter 2024 Results Release and Conference Call - GuruFocus
- 5 days ago - QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast - Wallstreet:Online
- 5 days ago - QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast - Business Wire
- 7 days ago - Qiage announces $300M buyback plan - Seeking Alpha
- 8 days ago - Qiagen NV Announces $300 Million Synthetic Share Repurchase Plan - GuruFocus
- 8 days ago - QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase - Wallstreet:Online
- 8 days ago - QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase - Business Wire